000 01181 a2200361 4500
005 20250513034541.0
264 0 _c19950905
008 199509s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/35.4.557
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScaglione, F
245 0 0 _aPenetration of pefloxacin and ciprofloxacin into lung tissue.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cApr 1995
300 _a557-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter; Randomized Controlled Trial
650 0 4 _a4-Quinolones
650 0 4 _aAnti-Infective Agents
_xblood
650 0 4 _aCiprofloxacin
_xblood
650 0 4 _aFluoroquinolones
650 0 4 _aHumans
650 0 4 _aLung
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aQuinolones
_xblood
650 0 4 _aPefloxacin
700 1 _aMezzetti, M
700 1 _aArcidiacono, M M
700 1 _aGattei, G
700 1 _aFraschini, F
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 35
_gno. 4
_gp. 557-9
856 4 0 _uhttps://doi.org/10.1093/jac/35.4.557
_zAvailable from publisher's website
999 _c7628430
_d7628430